Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cyclosporine A may help treat hair loss by blocking a protein that inhibits hair growth.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Alopecia is rare after organ transplants but more common in females, Hispanic patients, and pancreas recipients.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Blocking certain immune signals can reduce skin damage from radiation therapy.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Careful management of blood thinners is crucial for lupus patients with APS.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Cyclosporin A is highly toxic to rats, causing severe health issues and death.

A woman experienced hair loss, nail changes, bone marrow suppression, and low blood protein after taking azathioprine.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Hair regrowth improved, but quality of life did not.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

Recognizing and treating overlap syndrome in connective tissue diseases is crucial.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.